植入物乳房再造感染微生物学:系统综述
该系统综述纳入25项研究、25177例植入物乳房再造,感染率为5.4%,感染中培养阳性率为74.5%。革兰阳性菌最常见(68.6%),以葡萄球菌属(51%)为主,其次为假单胞菌;早期感染、放疗及脱细胞真皮基质使用者的培养阳性率较低,而化疗患者较高。
要点
- 植入物乳房再造感染率为5.4%,培养阳性率为74.5%。
- 最常见病原体为葡萄球菌属(51%)和假单胞菌。
- 早期感染、放疗和脱细胞真皮基质与较低培养阳性率相关。
核心结论
- 植入物乳房再造感染中最常报告的微生物为葡萄球菌属和假单胞菌。
- 最高25.5%的感染培养阴性,早期感染、放疗和脱细胞真皮基质者阴性率更高。
研究设计与样本
- 遵循PRISMA指南的系统综述,纳入报告乳房植入物感染率和培养结果的文献。
- 共纳入25项研究,涵盖25177例植入物乳房再造。
主要发现
- 1356例再造(5.4%)报告植入物感染,其中74.5%培养阳性。
- 革兰阳性菌占68.6%,葡萄球菌属占51%,其次为假单胞菌。
- 亚组分析显示早期感染培养阳性率63% vs 88%,放疗82% vs 93%,脱细胞真皮基质90% vs 100%。
- 接受化疗者培养阳性率更高(94% vs 83%)。
关键数值与推荐
- 植入物乳房再造感染率5.4%(1356/25177)。
- 感染培养阳性率74.5%,阴性率最高25.5%。
- 革兰阳性菌68.6%,葡萄球菌属51%。
临床怎么用
- 可参考葡萄球菌属和假单胞菌覆盖经验性抗菌治疗。
- 早期感染、放疗或使用脱细胞真皮基质者培养可能阴性,需结合临床判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postsurgical complications have been an increasing concern for hospitals, particularly in light of payment reform. The costs to the health care system are increasing in light of Medicare penalties for readmissions for certain conditions. Surgical site infection following implant-based breast reconstruction (IBR) remains challenging. The rates of positive cultures and isolated microorganisms in IBR are unknown. This systematic review summarizes the reported microorganisms and positive culture rates in the existing literature. METHODS: A systematic review was performed using the guidelines outlined in Preferred Reporting Items for Systematic Reviews and Meta-analyses. Articles were included if breast implant infection rates and culture results were reported. Further subgroup analysis of culture positive infections was performed. RESULTS: A total of 25 studies were included, encompassing 25,177 IBR. Implant infections were reported in 1356 reconstructions (5.4%). Cultures were positive in 74.5% of infections. Gram-positive bacteria were the most common (68.6%), of which Staphylococcus species (51%) was the most isolated pathogen, followed by Pseudomonas. A subgroup analysis showed that early infections (63% vs 88%), radiotherapy (82% vs 93%), and acellular dermal matrix use (90% vs 100%) were associated with lower positive culture rates than their respective counterparts. Patients who received chemotherapy had higher positive culture results (94% vs 83%). Isolated microorganisms also varied among the subgroups. CONCLUSIONS: This systematic review outlines reported microorganisms in IBR. Staphylococcus species and Pseudomonas were the most frequently reported microorganism. Negative cultures were reported in up to 25.5% of infections. Patients with early infections, radiotherapy, and acellular dermal matrix demonstrated higher negative culture rates. This review can help guide the use of empirical antimicrobial therapy in IBR.
引用
- Banuelos J, Abu-Ghname A, Asaad M, et al. Microbiology of Implant-Based Breast Reconstruction Infections: A Systematic Review. Ann Plast Surg. 2020. PMID: 31513083. doi:10.1097/SAP.0000000000001974
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。